EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy

Sudesh Prajapathi iD, Aditi Mohta iD, Bhushan Shah iD, Akshyaya Pradhan iD

European Cardiology Review · 17.08.2026

DOI: 10.15420/ecr.2026.35 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Cardiology Review, online erschienen am 17.08.2026. Verfasst von Sudesh Prajapathi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, All India Institute of Medical Sciences Bhopal, Madhya Pradesh, India. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hypertrophic cardiomyopathyODYSSEY-HCMcardiac myosin inhibitionmavacamtennon-obstructive hypertrophic cardiomyopathy

Autor:innen und Institutionen

  • Department of Cardiology, All India Institute of Medical Sciences Bhopal, Madhya Pradesh, India.
  • Department of Community Medicine, People's College of Medical Sciences and Research Centre, People's University Bhopal, India.
  • Department of Cardiology, King George's Medical University Lucknow, Uttar Pradesh, India.

ORCID-Profile: Sudesh Prajapathi, Aditi Mohta, Bhushan Shah, Akshyaya Pradhan

Zitieren

APA

Prajapathi, S., Mohta, A., Shah, B., & Pradhan, A. (2026). Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy. European Cardiology Review. https://doi.org/10.15420/ecr.2026.35

Vancouver

Prajapathi S, Mohta A, Shah B, Pradhan A. Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy. European Cardiology Review. 2026. doi:10.15420/ecr.2026.35

BibTeX
@article{Prajapathi2026,
  author = {Prajapathi, Sudesh and Mohta, Aditi and Shah, Bhushan and Pradhan, Akshyaya},
  title = {Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy},
  journal = {European Cardiology Review},
  year = {2026},
  doi = {10.15420/ecr.2026.35}
}
Kostenlos starten →